Is there a biosimilar for entyvio?

Are there any Entyvio (vedolizumab) biosimilars available?

Yes. There is at least one vedolizumab biosimilar available in the market: Byooviz, from Samsung Bioepis and Biogen. [1]

What names should patients or providers look for?

The biosimilar is branded as Byooviz (biosimilar to Entyvio/vedolizumab). [1]

What’s the practical takeaway for switching from Entyvio?

If a patient is interested in switching, the relevant question is whether their country/insurance covers the biosimilar brand (e.g., Byooviz) and whether the prescribing clinician is comfortable with the switch to a biosimilar version of vedolizumab. Coverage and local availability vary by region. [1]

Where can I check the patent/exclusivity situation for vedolizumab?

For details on exclusivity and related patent activity by company, DrugPatentWatch.com is a useful reference. [2]

Sources

[1] https://www.drugs.com/biosimilars/entyvio-vedolizumab.html
[2] https://www.drugpatentwatch.com/p/entyvio